| __timestamp | Vericel Corporation | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 17293000 | 60987000 |
| Thursday, January 1, 2015 | 26470000 | 125542000 |
| Friday, January 1, 2016 | 28307000 | 210460000 |
| Sunday, January 1, 2017 | 30354000 | 275119000 |
| Monday, January 1, 2018 | 32160000 | 409539000 |
| Tuesday, January 1, 2019 | 37571000 | 547758000 |
| Wednesday, January 1, 2020 | 39951000 | 736300000 |
| Friday, January 1, 2021 | 50159000 | 904200000 |
| Saturday, January 1, 2022 | 54577000 | 1080300000 |
| Sunday, January 1, 2023 | 61940000 | 1262200000 |
| Monday, January 1, 2024 | 1530500000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated and Vericel Corporation have shown distinct trajectories in their cost of revenue. From 2014 to 2023, Vertex Pharmaceuticals experienced a staggering 1,970% increase in cost of revenue, reflecting its aggressive expansion and investment in innovative treatments. In contrast, Vericel Corporation's cost of revenue grew by approximately 258%, indicating steady growth and a focus on niche markets.
These trends offer a window into the strategic priorities and market positioning of these two industry players.
Cost of Revenue Comparison: Novo Nordisk A/S vs Vertex Pharmaceuticals Incorporated
Cost of Revenue: Key Insights for AbbVie Inc. and Vertex Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: Merck & Co., Inc. vs Vertex Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Vericel Corporation
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Intra-Cellular Therapies, Inc.
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and ADMA Biologics, Inc.
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Bausch Health Companies Inc.'s Expenses
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Dyne Therapeutics, Inc.
Cost of Revenue Trends: PTC Therapeutics, Inc. vs Vericel Corporation
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Vericel Corporation and Evotec SE's Expenses